Spencer Pharmaceutical (SPPH)

[$on_myMind]

"Having both Dr. Mircea Mateescu (announced June 15, 2010) and Dr. Canh on the Spencer Pharmaceutical advisory board and leading the Company's research goals are all positives in our collective efforts to successfully commercialize our technologies. We warmly welcome Dr. Canh," stated Mr. Ian Morrice, EVP and Director of Spencer Pharmaceutical Inc. Furthermore, "Although we originally targeted Diabetes, our proprietary technology also applies to the multibillion dollar generic drug market," reiterated Mr. Morrice.